Search research articles
Contact Us
Filters
Showing results (171-180 of 259) with videos related to
Page
of 26
Sort By:
Rheumatology (Oxford, England)
|
February 18, 2011
Absence of up-regulation for a proliferation-inducing ligand in Sjögren's sialadenitis lesions
Tommaso Lombardi, Solange Moll, Pierre Youinou, et al.
Arthritis Care & Research
|
February 4, 2012
Evaluation of cardiovascular risk in patients with rheumatoid arthritis: do cardiovascular biomarkers offer added predictive ability over established clinical risk scores?
Axel Finckh, Delphine S Courvoisier, Sabrina Pagano, et al.
Arthritis Research & Therapy
|
March 5, 2013
The severity of experimental arthritis is independent of IL-36 receptor signaling
Céline Lamacchia, Gaby Palmer, Emiliana Rodriguez, et al.
Arthritis Research & Therapy
|
July 7, 2007
Expression and function of junctional adhesion molecule-C in human and experimental arthritis
Gaby Palmer, Nathalie Busso, Michel Aurrand-Lions, et al.
Rheumatology (Oxford, England)
|
July 31, 2019
IL-18 as therapeutic target in a patient with resistant systemic juvenile idiopathic arthritis and recurrent macrophage activation syndrome
Shima Yasin, Krista Solomon, Scott W Canna, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 22, 2006
Indirect effects of leptin receptor deficiency on lymphocyte populations and immune response in db/db mice
Gaby Palmer, Michel Aurrand-Lions, Emmanuel Contassot, et al.
Swiss Medical Weekly
|
December 24, 2013
Recommendations for the use of ultrasound in rheumatoid arthritis: literature review and SONAR score experience
Pascal Zufferey, Giorgio Tamborrini, Cem Gabay, et al.
Lancet (London, England)
|
March 22, 2013
Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial
Cem Gabay, Paul Emery, Ronald van Vollenhoven, et al.
Scandinavian Journal of Gastroenterology
|
July 9, 2008
Impaired counter-regulation of interleukin-1 by the soluble IL-1 receptor type II in patients with chronic liver disease
Othmar Ludwiczek, Edouard Vannier, Alexander Moschen, et al.
Cytokine
|
June 4, 2016
Interleukin-36 potently stimulates human M2 macrophages, Langerhans cells and keratinocytes to produce pro-inflammatory cytokines
Damien Dietrich, Praxedis Martin, Vincent Flacher, et al.
Page
of 26
Search research articles
Search
Showing results (171-180 of 259) with videos related to
Sort By:
Page
of 26
Rheumatology (Oxford, England)
|
February 18, 2011
Absence of up-regulation for a proliferation-inducing ligand in Sjögren's sialadenitis lesions
Tommaso Lombardi, Solange Moll, Pierre Youinou, et al.
Arthritis Care & Research
|
February 4, 2012
Evaluation of cardiovascular risk in patients with rheumatoid arthritis: do cardiovascular biomarkers offer added predictive ability over established clinical risk scores?
Axel Finckh, Delphine S Courvoisier, Sabrina Pagano, et al.
Arthritis Research & Therapy
|
March 5, 2013
The severity of experimental arthritis is independent of IL-36 receptor signaling
Céline Lamacchia, Gaby Palmer, Emiliana Rodriguez, et al.
Arthritis Research & Therapy
|
July 7, 2007
Expression and function of junctional adhesion molecule-C in human and experimental arthritis
Gaby Palmer, Nathalie Busso, Michel Aurrand-Lions, et al.
Rheumatology (Oxford, England)
|
July 31, 2019
IL-18 as therapeutic target in a patient with resistant systemic juvenile idiopathic arthritis and recurrent macrophage activation syndrome
Shima Yasin, Krista Solomon, Scott W Canna, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 22, 2006
Indirect effects of leptin receptor deficiency on lymphocyte populations and immune response in db/db mice
Gaby Palmer, Michel Aurrand-Lions, Emmanuel Contassot, et al.
Swiss Medical Weekly
|
December 24, 2013
Recommendations for the use of ultrasound in rheumatoid arthritis: literature review and SONAR score experience
Pascal Zufferey, Giorgio Tamborrini, Cem Gabay, et al.
Lancet (London, England)
|
March 22, 2013
Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial
Cem Gabay, Paul Emery, Ronald van Vollenhoven, et al.
Scandinavian Journal of Gastroenterology
|
July 9, 2008
Impaired counter-regulation of interleukin-1 by the soluble IL-1 receptor type II in patients with chronic liver disease
Othmar Ludwiczek, Edouard Vannier, Alexander Moschen, et al.
Cytokine
|
June 4, 2016
Interleukin-36 potently stimulates human M2 macrophages, Langerhans cells and keratinocytes to produce pro-inflammatory cytokines
Damien Dietrich, Praxedis Martin, Vincent Flacher, et al.
Page
of 26